Synopsis
0
USDMF
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Ethypharm is an international Pharma company with European roots manufacturing and commercializing essential drugs all over the world.
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Methadon \"Martindale Pharma\"
Dosage Form : Oral Solution
Dosage Strength : 2mg/ml
Packaging :
Approval Date : 27-05-2009
Application Number : 28104399108
Regulatory Info : Prescription
Registration Country : Denmark
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
57
PharmaCompass offers a list of Levomethadone API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Levomethadone manufacturer or Levomethadone supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levomethadone manufacturer or Levomethadone supplier.
A l-Polamidon hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of l-Polamidon hydrochloride, including repackagers and relabelers. The FDA regulates l-Polamidon hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. l-Polamidon hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of l-Polamidon hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A l-Polamidon hydrochloride supplier is an individual or a company that provides l-Polamidon hydrochloride active pharmaceutical ingredient (API) or l-Polamidon hydrochloride finished formulations upon request. The l-Polamidon hydrochloride suppliers may include l-Polamidon hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of l-Polamidon hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A l-Polamidon hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a l-Polamidon hydrochloride Certificate of Suitability (COS). The purpose of a l-Polamidon hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of l-Polamidon hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of l-Polamidon hydrochloride to their clients by showing that a l-Polamidon hydrochloride CEP has been issued for it. The manufacturer submits a l-Polamidon hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a l-Polamidon hydrochloride CEP holder for the record. Additionally, the data presented in the l-Polamidon hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the l-Polamidon hydrochloride DMF.
A l-Polamidon hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. l-Polamidon hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of l-Polamidon hydrochloride suppliers with CEP (COS) on PharmaCompass.
A l-Polamidon hydrochloride written confirmation (l-Polamidon hydrochloride WC) is an official document issued by a regulatory agency to a l-Polamidon hydrochloride manufacturer, verifying that the manufacturing facility of a l-Polamidon hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting l-Polamidon hydrochloride APIs or l-Polamidon hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a l-Polamidon hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of l-Polamidon hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
l-Polamidon hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of l-Polamidon hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right l-Polamidon hydrochloride GMP manufacturer or l-Polamidon hydrochloride GMP API supplier for your needs.
A l-Polamidon hydrochloride CoA (Certificate of Analysis) is a formal document that attests to l-Polamidon hydrochloride's compliance with l-Polamidon hydrochloride specifications and serves as a tool for batch-level quality control.
l-Polamidon hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each l-Polamidon hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
l-Polamidon hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (l-Polamidon hydrochloride EP), l-Polamidon hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (l-Polamidon hydrochloride USP).
